ADMA BIOLOGICS, INC.

ADMA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $2.5B · 647 employees
398
SEC Filings
$12.79
Close 2026-11-09
647
Employees

Business Summary

ADMA Biologics is a U.S.-based commercial biopharmaceutical company that manufactures, markets, and develops specialty biologics for immunodeficient patients. Its FDA-approved products include ASCENIV and BIVIGAM (IVIG products for Primary Immunodeficiency) and Nabi-HB (Hepatitis B Immune Globulin). The company operates a plasma fractionation facility in Boca Raton, FL, and ten plasma collection centers through its ADMA BioCenters subsidiary, supporting both internal manufacturing and third-party plasma sales.

Latest Stock Quote

ADMA 2026-11-09 $12.79 O:$12.9 H:$13.0578 L:$12.4814 Vol:3.4M VWAP:$12.8233
origin leaf: null

Next Earnings

expected 2027-02-03

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-252025-12-310001140361-26-006815EDGAR90K words
2025-03-182024-12-310001140361-25-009257EDGAR90K words
2024-02-282023-12-310001140361-24-010147EDGAR85K words
2023-03-232022-12-310001140361-23-013467EDGAR79K words
2022-03-242021-12-310001140361-22-011030EDGAR81K words
2021-03-252020-12-310001193805-21-000411EDGAR74K words
2020-03-132019-12-310001193805-20-000348EDGAR68K words
2019-03-132018-12-310001193805-19-000281EDGAR75K words
2018-03-292017-12-310001193805-18-000470EDGAR70K words
2017-02-242016-12-310001193805-17-000330EDGAR68K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-042026-09-300001140361-26-041977EDGAR56K words
2026-08-052026-06-300001140361-26-031445EDGAR55K words
2025-11-052025-09-300001140361-25-040578EDGAR50K words
2025-08-062025-06-300001140361-25-029177EDGAR51K words
2025-05-072025-03-310001140361-25-017747EDGAR44K words
2024-11-072024-09-300001140361-24-045693EDGAR52K words
2024-08-082024-06-300001140361-24-036432EDGAR51K words
2024-05-092024-03-310001140361-24-025226EDGAR46K words
2023-11-082023-09-300001140361-23-052109EDGAR53K words
2023-08-092023-06-300001140361-23-038843EDGAR52K words
2023-05-102023-03-310001140361-23-023920EDGAR49K words
2022-11-092022-09-300001140361-22-040738EDGAR52K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-040001140361-26-041959EDGAR10K words
2026-08-050001140361-26-031423EDGAR7K words
2026-03-270001140361-26-011569EDGAR3K words
2026-03-020001140361-26-007230EDGAR1K words
2026-02-250001140361-26-006781EDGAR6K words
2026-01-120001140361-26-000906EDGAR4K words
2025-11-050001140361-25-040539EDGAR5K words
2025-08-060001140361-25-029143EDGAR5K words
2025-06-040001140361-25-021440EDGAR1K words
2025-05-070001140361-25-017704EDGAR5K words

398 total filings indexed. 366 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE ABPO — Abpro Holdings, Inc.

Tags

primary-immunodeficiency-disease-(pidd)-treatment hepatitis-b-post-exposure-prophylaxis plasma-collection-and-third-party-plasma-supply contract-manufacturing-and-laboratory-services immunocompromised-patient-specialty-biologics fda-biologics-license-application-(bla) prior-approval-supplement-(pas) healthcare-common-procedure-coding-system-(hcpcs)-j-code-(j1554) korean-ministry-of-food-and-drug-safety-(mfds)-approval fda-plasma-collection-center-licensing commissioners-national-priority-voucher-(cnpv)

Company Identity

CIK0001368514
TickerADMA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
HeadquartersBoca Raton, Florida
Websitehttps://www.admabiologics.com
Listed2013-10-17

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 682009f707f1feccba1a6ca364cb7b94a7fc99203af5887c856d4ad2f2fd96c8
parent: 854266f7228b051bdeb5905c59181861c00151641e037106fb59fd896dd8165b
content hash: e760c2003bf777e0ccd4ad2fcdaa091b717a9b3977ae929abda49872456a4240
signed: 2026-11-16T19:00:16.057Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ADMA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ADMA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ADMA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.